A drug that isn't even approved yet is already being copied and sold on the black market.

As weight-loss drugs have become increasingly popular, attention has turned towards what could be the next big development: retatrutide. Developed by Eli Lilly, the experimental drug is currently being studied in Phase 3 trials and has already attracted attention from consumers and fitness influencers.

So how does an average consumer get their hands on a drug that hasn't even been approved yet? It is probably a lot more available than you might think, vials which have become known as 'reta' are being sold around the UK in gyms, beauty salons, hairdressers and even by street florists. If you don't want to make the trip outside, you can even get it delivered after a quick search on social media.

Table of Contents

1. What Makes Retatrutide Different?

2. The Risks Behind the Hype

3. Real Experiences, Real Risks

4. Why Demand Is Outpacing Regulation

5. The Fight Against the Counterfeit Market

6. Sources

What Makes Retatrutide Different?

So what makes retatrutide different from the weight-loss drugs already dominating the market? The answer is that it doesn't target one or two hormonal pathways, it targets three.

  • GLP-1: helps people feel fuller and reduces appetite.
  • GIP: works alongside GLP-1 to influence appetite and how the body handles food and glucose.
  • Glucagon: can increase energy expenditure and affect how the body uses stored energy.

In simple terms, retatrutide is designed to influence several systems involved in appetite and energy use at the same time. This is one reason researchers are so interested in its potential.

The Risks Behind the Hype

Whilst the information above points to the new drug sounding like it is God's gift to weight-loss medication, there are some dangers that all users should be aware of. Firstly, the counterfeit products may contain unknown ingredients, contaminants, too much or too little active substance, or the wrong substances entirely.

Side effects have been reported in trials of authentic retatrutide, including gastrointestinal symptoms such as nausea, vomiting and diarrhoea. But when the product itself is counterfeit, the risks become even harder to predict: users may not know exactly what they are injecting, how much active substance it contains, or whether it contains contaminants or entirely different substances.

Real Experiences, Real Risks

Tom Davies, a fitness influencer from Brighton whose channel focuses on peptides and their potential benefits, experienced the risks of counterfeit products first-hand. His first order, supplied by a Chinese manufacturer, left him violently ill for three days and nearly resulted in a hospital visit. He believed he was taking the dose provided by the supplier but later discovered he had taken eight times that amount.

Lisa's experience has been very different. She reported losing as much as 3kg a week and said she had noticed other benefits. But one person's experience cannot tell us whether a drug is safe or effective for everyone.

Why Demand Is Outpacing Regulation

Perhaps the most revealing part of the retatrutide story isn't just that counterfeiters are selling it, but that there's already a market of people willing to buy it. Social media has made weight-loss injections increasingly visible, making them seem more normalised and accessible every day. Fitness influencers make experimental compounds far more familiar than they really are. When a product is only a few clicks away, the line between 'promising new medication' and 'something anyone who wants to lose weight can safely inject' can become dangerously blurred.

There is also no guarantee that an experimental drug will ultimately make it to the market. Historically, only around half of drugs entering Phase 3 trials go on to receive FDA approval. Until retatrutide completes the necessary trials and regulatory review, its eventual availability remains uncertain.

The Fight Against the Counterfeit Market

Eli Lilly is trying to fight the problem, reporting over 14,000 illegal websites, ads, and social media posts. The UK's MHRA has raided illegal production sites, recently a major Northampton factory where over 2,000 unlicensed retatrutide pens were seized.

The irony is that retatrutide may eventually become an important development in the treatment of obesity. But while scientists are still working out exactly how safe and effective it is, the internet has already decided that people want it. The counterfeit market is what happens when demand moves faster than regulation.

If you're considering a weight-loss treatment, the safest route is always a licensed, prescription-only medicine obtained through a registered pharmacy following a proper clinical assessment, never an unregulated vial with no verifiable origin. You can browse our range of weight loss treatments or start a consultation with our clinical team to discuss what's actually approved and appropriate for you.

Sources

Posted: September 16, 2026
Updated : September 16 2026
Categories: Weight Loss
Author: Gurdev Sehmi